Overview

Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Today metastatic breast cancer is regarded as cureless. The treatment is palliative in intent and the goals of treatment include improvement of quality of life and if possible prolongation of life. Treatment in metastatic cancer will usually involve hormone therapy and/or chemotherapy. Weekly application of chemotherapeutical drugs may lead to less drug concentrations in healthy tissue and therefore toxicities maý be reduced.
Phase:
Phase 2
Details
Lead Sponsor:
Claudia Lorenz-Schlüter
Treatments:
Albumin-Bound Paclitaxel
Doxorubicin
Liposomal doxorubicin
Paclitaxel